Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Biodexa Pharmaceuticals (BDRX)

Annual Return

Over the past 3 years, BDRX has had an average annual return of +0%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, BDRX has had an average annual return of -83.10%, underperforming the benchmark SPY, which returned +13.88% annual.

Over the past 10 years, BDRX has had an average annual return of -69.41%, underperforming the benchmark SPY, which returned +15.44% annual.

Since Dec 7, 2015, BDRX has had an average annual return of -69.59%, underperforming the benchmark SPY, which returned +14.94% annual.

202320222021202020192018201720162015
-80.00%-82.76%-43.14%-45.74%-55.45%-81.49%-69.64%-43.10%-34.01%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023-20.00%-25.00%-33.33%-50.00%+0%+0%-80.00%
2022-6.90%-0%-11.11%-25.00%-5.56%-11.76%+20%+11.11%-50.00%+10%-18.18%-44.44%-82.76%
2021+13.73%+6.90%-6.45%-6.90%-3.70%+9.62%-10.53%-1.96%-6.00%-2.13%-13.04%-27.50%-43.14%
2020+5.32%-29.29%-30.00%+63.27%-57.50%+8.82%+51.35%+12.50%-22.22%-0%+0%+4.08%-45.74%
2019-21.80%+353.33%-33.29%-49.50%-20.24%-2.49%+7.14%-19.52%-1.18%-23.95%-27.56%+2.17%-55.45%
2018+27.72%-2.82%-20.21%-12.05%-0.50%-5.67%-9.44%+38.27%-32.65%-27.35%-36.08%-42.19%-81.49%
2017+14.14%-9.22%-8.74%+6.14%+0.72%-7.53%+3.11%-12.85%-33.13%-8.39%-14.80%-30.74%-69.64%

Drawdown analysis of Biodexa Pharmaceuticals (BDRX)

The maximum drawdown for the BDRX was -99.99%, occurring on Apr 10, 2023. This drawdown has not yet recovered.

The current BDRX drawdown is -99.99%.

Since Dec 7, 2015 BDRX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Dec 7, 20151846Apr 10, 2023OngoingOngoingOngoing